Sara Bonstein Insider Profile
4 Followers
Sara Bonstein, Director at Xilio Therapeutics, holds ― shares in Xilio Therapeutics (Ticker: XLO), holds 69.08K shares in Insmed (Ticker: INSM), holds 41.39K shares in OncoSec Medical (Ticker: ONCSQ). Most recently, Sara Bonstein ― shares of Xilio Therapeutics on ― for an estimated value of ―.
Profitable Transactions
8 out of 21 Profitable Transactions
Average Return
-37.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sara Bonstein holds in companies
Most Profitable Insider Trade
Stock:
Advaxis
(ADXS)
(ADXS)
Rating:Informative Sell
Date:Jan 03, 2018 - Jan 03, 2019
Return:+91.50%
The most profitable trade made by Sara Bonstein
Sara Bonstein's Trading History
Xilio Therapeutics
―
Director
―
―
Advaxis
Apr 03, 2018
―
Uninformative Buy
1.84K
$136.68K
OncoSec Medical
Jan 21, 2020
CFO/COO
Informative Sell
2.81K
―
Insmed
Jun 05, 2026
CFO
Informative Sell
245.86K
$8.72M
scPharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Sara Bonstein's performance on stock
You May Also Like
Sara Bonstein insider profile FAQ
What is the percentage of profitable transactions made by Sara Bonstein?
The percentage of profitable transactions made by Sara Bonstein is 38%.
What is the average return per transaction made by Sara Bonstein?
The average return per transaction made by Sara Bonstein is -37.40%.
What stocks does Sara Bonstein hold?
Sara Bonstein holds: XLO, ADXS, ONCSQ, INSM, SCPH stocks.
What was Sara Bonstein’s latest transaction?
Sara Bonstein latest transaction was an Uninformative Buy of ―.
What was Sara Bonstein's most profitable transaction?
Sara Bonstein’s most profitable transaction was an Informative Sell of ADXS stock on January 3, 2018. The return on the trade was 91.50%.
What is Sara Bonstein's role in Xilio Therapeutics?
Sara Bonstein's role in Xilio Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.